Okyo Pharma Ltd (OKYO)

$1.66

+0.07

(+4.73%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.57
    $1.73
    $1.66
    downward going graph

    5.42%

    Downside

    Day's Volatility :9.25%

    Upside

    4.05%

    downward going graph
  • $1.09
    $3.07
    $1.66
    downward going graph

    34.34%

    Downside

    52 Weeks Volatility :64.5%

    Upside

    45.93%

    downward going graph

Returns

PeriodOkyo Pharma LtdIndex (Russel 2000)
3 Months
22.06%
0.0%
6 Months
3.11%
0.0%
1 Year
36.07%
0.0%
3 Years
-54.14%
-19.4%

Highlights

Market Capitalization
52.7M
Book Value
- $0.08
Earnings Per Share (EPS)
-0.61
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-173.43%
Return On Equity TTM
-2968.51%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-3.6M
EBITDA
-13.2M
Diluted Eps TTM
-0.61
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Okyo Pharma Ltd(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Technicals Summary

Sell

Neutral

Buy

Okyo Pharma Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Okyo Pharma Ltd
Okyo Pharma Ltd
33.87%
3.11%
36.07%
-54.14%
-54.14%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Okyo Pharma Ltd
Okyo Pharma Ltd
NA
NA
NA
0.0
-29.69
-1.73
NA
-0.08
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Okyo Pharma Ltd
Okyo Pharma Ltd
Buy
$52.7M
-54.14%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Okyo Pharma Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 23.8%

Institutional Holdings

  • Barclays PLC

    2.58%
  • Susquehanna International Group, LLP

    0.06%
  • HPM Partners LLC

    0.04%
  • Geode Capital Management, LLC

    0.04%
  • HSBC Holdings PLC

    0.04%

Company Information

Organization
Okyo Pharma Ltd
Employees
8
CEO
Dr. Gary S. Jacob Ph.D.
Industry
Miscellaneous

FAQs